Evaxion Biotech A/S (EVAX)
USD 0.88
(-9.28%)
USD 0.88
(-9.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 73.11 Thousand | - | - | - | - | - |
| Cost of Revenue | - | 571.31 Thousand | 343.45 Thousand | 105.71 Thousand | 80.98 Thousand | 73.92 Thousand |
| Gross Profit | 73.11 Thousand | -571.31 Thousand | -343.45 Thousand | -105.71 Thousand | -80.98 Thousand | -73.92 Thousand |
| Operating Expenses | 22.27 Million | 25.26 Million | 25.83 Million | 16.56 Million | 10.86 Million | 5.62 Million |
| Selling, General and Administrative Expenses | 10.35 Million | 8.2 Million | 6.25 Million | 5.66 Million | 2.63 Million | 1.88 Million |
| Research and Development Expenses | 11.91 Million | 17.05 Million | 19.58 Million | 10.9 Million | 8.21 Million | 3.72 Million |
| Other Expenses | - | - | - | - | 16 Thousand | 15 Thousand |
| Cost and Expenses | 22.27 Million | 25.26 Million | 25.83 Million | 16.56 Million | 10.86 Million | 5.62 Million |
| Operating Income | -22.19 Million | -25.26 Million | -25.83 Million | -16.56 Million | -10.86 Million | -5.62 Million |
| Interest Expense | 897 Thousand | 1.5 Million | 915 Thousand | 223 Thousand | 1.22 Million | 698 Thousand |
| Income Tax Expense | -791.21 Thousand | -772 Thousand | -178 Thousand | -1.55 Million | -825 Thousand | -735 Thousand |
| Earnings before Tax | -22.91 Million | -23.94 Million | -24.71 Million | -16.57 Million | -12.02 Million | -6.27 Million |
| Net Income | -22.12 Million | -23.16 Million | -24.53 Million | -15.01 Million | -11.19 Million | -5.53 Million |
| Earnings Per Share Basic | -8.11 | -9.80 | -12.58 | -9.27 | -6.91 | -2.88 |
| Earnings Per Share Diluted | -8.11 | -9.80 | -12.58 | -9.27 | -6.91 | -2.88 |
| Weighted Average Shares Outstanding | 2.73 Million | 2.36 Million | 1.94 Million | 1.61 Million | 1.61 Million | 1.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.73 Million | 2.36 Million | 1.94 Million | 1.61 Million | 1.61 Million | 1.91 Million |
| Gross Margin | 1.00 | - | - | - | - | - |
| EBIT Margin | -292.74 | - | - | - | - | - |
| Profit Margin | -302.62 | - | - | - | - | - |
| EBITDA | -21.4 Million | -22.58 Million | -24.16 Million | -16.46 Million | -11.89 Million | -6.17 Million |
| Earnings Before Tax Margin | -303.60 | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 3.02 Million | 153.88 Thousand | 50.88 Thousand | 73.11 Thousand | 73.59 Thousand | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 3.02 Million | 153.88 Thousand | 50.88 Thousand | 73.11 Thousand | 73.59 Thousand | - |
| Operating Expenses | 4.76 Million | 4.73 Million | 4.43 Million | 21.68 Million | 4.47 Million | 5.76 Million |
| Selling, General and Administrative Expenses | 2.14 Million | 1.98 Million | 1.6 Million | - | 2.15 Million | 2.93 Million |
| Research and Development Expenses | 2.62 Million | 2.74 Million | 2.82 Million | - | 2.31 Million | 2.83 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 4.76 Million | 4.73 Million | 4.43 Million | 22.3 Million | 4.47 Million | 5.76 Million |
| Operating Income | -1.73 Million | -4.57 Million | -4.38 Million | -22.23 Million | -4.39 Million | -5.76 Million |
| Interest Expense | 385.21 Thousand | 225 Thousand | 246 Thousand | 897 Thousand | 111 Thousand | 182 Thousand |
| Income Tax Expense | -96.3 Thousand | -198.85 Thousand | -217.49 Thousand | -791.21 Thousand | -178.44 Thousand | -194 Thousand |
| Earnings before Tax | -2.03 Million | -6.39 Million | 973.72 Thousand | -22.95 Million | -4.73 Million | -5.87 Million |
| Net Income | -1.94 Million | -6.19 Million | 1.19 Million | -22.15 Million | -4.56 Million | -5.67 Million |
| Earnings Per Share Basic | -0.35 | -1.14 | 0.26 | - | -1.67 | -2.05 |
| Earnings Per Share Diluted | -0.35 | -1.14 | 0.26 | - | -1.67 | -2.05 |
| Weighted Average Shares Outstanding | 5.52 Million | 5.41 Million | 4.66 Million | 2.73 Million | 2.73 Million | 2.76 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.52 Million | 5.41 Million | 4.66 Million | 2.73 Million | 2.73 Million | 2.76 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | - |
| EBIT Margin | -0.55 | -29.50 | 24.02 | - | -62.35 | - |
| Profit Margin | -0.64 | -40.25 | 23.47 | -303.08 | -61.96 | - |
| EBITDA | -1.65 Million | -4.54 Million | 1.22 Million | - | -4.58 Million | -5.69 Million |
| Earnings Before Tax Margin | -0.57 | -29.75 | -86.20 | -304.07 | -59.78 | - |
TLO
JHS
ULTRACEMCO
GOKULAGRO
TC
EXPLEOSOL